Federal Circuit Gives Teva Go-Ahead For Generic Biaxin
The U.S. Court of Appeals for the Federal Circuit Thursday threw out a preliminary injunction barring Israeli drug maker Teva Pharmaceutical Industries Ltd. from selling a generic version of Abbott Laboratories'...To view the full article, register now.
Already a subscriber? Click here to view full article